How I do it: sequential robot-assisted stereotactic biopsy and laser interstitial thermal therapy for epilepsy associated with brain tumors - Scorecard - MDSpire

How I do it: sequential robot-assisted stereotactic biopsy and laser interstitial thermal therapy for epilepsy associated with brain tumors

  • By

  • Oumaima Aboubakr

  • Bertrand Mathon

  • December 3, 2025

  • 0 min

Share

Clinical Scorecard: A Stepwise Approach to Robot-Assisted Stereotactic Biopsy and Laser Interstitial Thermal Therapy for Epilepsy Linked to Brain Tumors

At a Glance

CategoryDetail
ConditionDrug-resistant focal epilepsy associated with brain tumors
Key MechanismsMinimally invasive laser ablation using MR thermometry-guided thermal lesioning combined with robot-assisted stereotactic biopsy
Target PopulationAdult and pediatric patients with focal, circumscribed, eloquent, or deep brain lesions including tumors
Care SettingNeurosurgical operating room with intraoperative CT and MRI suite for real-time monitoring

Key Highlights

  • LITT produces controlled spheroid-shaped thermal lesions via a 980 nm laser fiber with real-time MR thermometry monitoring.
  • Robot-assisted stereotactic biopsy enables precise histomolecular diagnosis prior to LITT in deep-seated or difficult-to-access brain tumors.
  • Thermal barriers such as fissures, sulci, blood vessels, and CSF spaces affect heat diffusion and must be considered during planning.

Guideline-Based Recommendations

Diagnosis

  • Perform presurgical evaluation including MRI to identify tumor characteristics and epileptogenic focus.
  • Use robot-assisted stereotactic biopsy with intraoperative histological smear to confirm diagnosis and minimize sample number.

Management

  • Employ a stepwise approach: first robot-assisted biopsy, then placement of laser fiber for LITT.
  • Use MR thermometry for real-time temperature monitoring to achieve irreversible thermal ablation at 52 °C threshold.
  • Plan surgical trajectory considering anatomical thermal barriers and sinks to optimize ablation extent.

Monitoring & Follow-up

  • Confirm fiber positioning and absence of hemorrhage or air bubbles with T1-weighted MRI post-biopsy.
  • Monitor ablation zone and brain temperature in real-time using MR thermometry during LITT.
  • Use diffusion-weighted and T2-FLAIR MRI sequences post-ablation to confirm cytotoxic edema and contrast-enhanced T1 to assess blood–brain barrier disruption.

Risks

  • Air bubbles from biopsy can cause signal dropout and interfere with MR thermometry monitoring.
  • Thermal sinks such as blood vessels and CSF spaces may reduce ablation efficacy.
  • Potential for hemorrhage or tissue damage if trajectory or temperature control is inadequate.

Patient & Prescribing Data

Patients with drug-resistant focal epilepsy linked to deep-seated brain tumors, including dysembryoplastic neuroepithelial tumors

LITT combined with robot-assisted biopsy offers a minimally invasive option when craniotomy is challenging, enabling targeted ablation with histological confirmation.

Clinical Best Practices

  • Use skull-mounted fiducial markers and intraoperative CT for accurate registration and robotic guidance.
  • Secure head in Mayfield clamp and use ROSA robotic system for precise instrument alignment.
  • Perform minimal hair shaving and use progressively smaller reducers for burr hole drilling and dura opening.
  • Obtain two tissue samples with rapid suction for intraoperative histology to confirm diagnosis.
  • Calculate and mark catheter length precisely to match target depth minus reducer height.
  • Advance cooling sheath and secure fiber with guidance bolt before MRI transport.
  • Monitor for air bubbles and hemorrhage post-biopsy and adjust procedure accordingly.
  • Deliver multiple adjacent spheroid ablations by retracting fiber to cover entire target volume.

References

Original Source(s)

Related Content